Literature DB >> 19731359

Family psychosocial risk, distress, and service utilization in pediatric cancer: predictive validity of the Psychosocial Assessment Tool.

Melissa A Alderfer1, Ifigenia Mougianis, Lamia P Barakat, David Beele, Susan DiTaranto, Wei-Ting Hwang, Anne T Reilly, Anne E Kazak.   

Abstract

BACKGROUND: The way families negotiate diagnosis and early treatment for pediatric cancer sets the stage for their adaptation throughout treatment and survivorship. The Psychosocial Assessment Tool (PAT) is a brief parent-report screener capable of systematically identifying families at risk for problems of adaptation. The current study evaluated stability and predictive validity of PAT psychosocial risk classification with regard to distress, family functioning, and the use of psychosocial services over the first 4 months of treatment.
METHODS: Caregivers of children with cancer completed the PAT and measures of distress and family functioning at diagnosis and again 4 months into treatment. At the second time point, social workers completed checklists of services provided and rated the intensity of their work with each family. Referrals to psychologists also were tracked.
RESULTS: Psychosocial risk classification, based on the PAT, was stable across the first 4 months of cancer treatment; 57% to 69% of families remained at the same level of risk. PAT total scores did not differ across time, but subscale scores indicated increases in family and child (patient) problems and decreases in unhelpful beliefs. Families classified at higher levels of psychosocial risk at diagnosis had more distress, more family problems, and greater psychosocial service use 4 months into treatment.
CONCLUSIONS: Understanding and identifying risks for psychosocial adjustment difficulties within families of children with cancer, considering changes across treatment and beyond, is very complex. Despite evidence of the predictive validity of PAT, additional research is necessary to find ways to effectively use this screener in practice to guide intervention. Copyright (c) 2009 American Cancer Society.

Entities:  

Mesh:

Year:  2009        PMID: 19731359     DOI: 10.1002/cncr.24587

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  19 in total

1.  Assessing psychosocial risk in pediatric inflammatory bowel disease: validation of the Psychosocial Assessment Tool 2.0_General.

Authors:  Ahna L H Pai; Alayna Tackett; Elizabeth A Hente; Michelle M Ernst; Lee A Denson; Kevin A Hommel
Journal:  J Pediatr Gastroenterol Nutr       Date:  2014-01       Impact factor: 2.839

2.  Healthcare provider utility ratings of a psychosocial screening summary: from diagnosis to 6 months.

Authors:  Leandra Desjardins; Laurel Etkin-Spigelman; Kelly Hancock; Joanna Chung; Wendy Shama; Denise Mills; Sarah Alexander; Maru Barrera
Journal:  Support Care Cancer       Date:  2019-07-10       Impact factor: 3.603

3.  Children's psychological distress during pediatric HSCT: parent and child perspectives.

Authors:  Grace Chang; Sara J Ratichek; Christopher Recklitis; Karen Syrjala; Sunita K Patel; Lynnette Harris; Angie Mae Rodday; Hocine Tighiouart; Susan K Parsons
Journal:  Pediatr Blood Cancer       Date:  2011-05-25       Impact factor: 3.167

4.  A revision of the intensity of treatment rating scale: classifying the intensity of pediatric cancer treatment.

Authors:  Anne E Kazak; Matthew C Hocking; Richard F Ittenbach; Anna T Meadows; Wendy Hobbie; Branlyn Werba DeRosa; Ann Leahey; Leslie Kersun; Anne Reilly
Journal:  Pediatr Blood Cancer       Date:  2011-08-19       Impact factor: 3.167

5.  The association of psychosocial screening and service provision in pediatric oncology: the Psychosocial Assessment Tool (PAT2.0) into clinical practice.

Authors:  M C McCarthy; S DeGraves; C E Wakefield; M J Bowden; L V Marks; L K Williams
Journal:  Support Care Cancer       Date:  2016-02-09       Impact factor: 3.603

6.  Post-traumatic disorder symptoms and blunted diurnal cortisol production in partners of prostate cancer patients.

Authors:  Kamala S Thomas; Julienne E Bower; Timothy J Williamson; Michael A Hoyt; David Wellisch; Annette L Stanton; Michael Irwin
Journal:  Psychoneuroendocrinology       Date:  2012-01-03       Impact factor: 4.905

Review 7.  Screening for psychosocial risk in pediatric cancer.

Authors:  Anne E Kazak; Moriah Brier; Melissa A Alderfer; Anne Reilly; Stephanie Fooks Parker; Stephanie Rogerwick; Susan Ditaranto; Lamia P Barakat
Journal:  Pediatr Blood Cancer       Date:  2012-04-10       Impact factor: 3.167

8.  Using formative evaluation to plan for electronic psychosocial screening in pediatric oncology.

Authors:  Jordan Gilleland Marchak; Sean N Halpin; Cam Escoffery; Shadé Owolabi; Ann C Mertens; Karen Wasilewski-Masker
Journal:  Psychooncology       Date:  2020-10-20       Impact factor: 3.894

9.  Psychosocial Screening in Sickle Cell Disease: Validation of the Psychosocial Assessment Tool.

Authors:  Steven K Reader; Colleen N Keeler; Fang Fang Chen; Nicole M Ruppe; Diana L Rash-Ellis; Jean R Wadman; Robin E Miller; Anne E Kazak
Journal:  J Pediatr Psychol       Date:  2020-05-01

10.  Cumulative family risk predicts sibling adjustment to childhood cancer.

Authors:  Kristin A Long; Anna L Marsland; Melissa A Alderfer
Journal:  Cancer       Date:  2013-04-10       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.